Alexander Seelenberger Farba

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is an asset management firm headquartered in Vitacura, Chile. The firm was founded by Juan Carlos Délano Valenzuela and is a subsidiary of Aurus Gestión de Inversiones SpA. Aurus Capital provides investment advice to individual and institutional clients.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is a venture capital firm located in Chile. It was founded in 2008 and is headquartered in Santiago, Chile.

EchoPixel, Inc. develops medical imaging devices. It offers True 3D viewer 1.0 and True 3D medical education viewer. The firm’s products allows medical professionals to interact with patient-specific organs and tissue in an open 3D space emanating from a display, enabling doctors to immediately identify, evaluate, and dissect clinically significant structures in diagnostic, surgical planning and image guided treatment applications. The company was founded by Sergio Aguirre Valencia in 2005 and is headquartered Mountain View, CA.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is a venture capital firm located in Chile. It was founded in 2008 and is headquartered in Santiago, Chile.

Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile.

Levita Magnetics International Corp. provides magnetic surgical platform. The company was is headquartered in San Mateo, CA.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is an asset management firm headquartered in Vitacura, Chile. The firm was founded by Juan Carlos Délano Valenzuela and is a subsidiary of Aurus Gestión de Inversiones SpA. Aurus Capital provides investment advice to individual and institutional clients.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is a venture capital firm located in Chile. It was founded in 2008 and is headquartered in Santiago, Chile.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is a venture capital firm located in Chile. It was founded in 2008 and is headquartered in Santiago, Chile.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is an asset management firm headquartered in Vitacura, Chile. The firm was founded by Juan Carlos Délano Valenzuela and is a subsidiary of Aurus Gestión de Inversiones SpA. Aurus Capital provides investment advice to individual and institutional clients.

Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.

Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile.

Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is an asset management firm headquartered in Vitacura, Chile. The firm was founded by Juan Carlos Délano Valenzuela and is a subsidiary of Aurus Gestión de Inversiones SpA. Aurus Capital provides investment advice to individual and institutional clients.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is a venture capital firm located in Chile. It was founded in 2008 and is headquartered in Santiago, Chile.

Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile.

Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile.

Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile.

Aurus Capital SA Administradora General de Fondos (Aurus Capital) is a venture capital firm located in Chile. It was founded in 2008 and is headquartered in Santiago, Chile.

Levita Magnetics International Corp. provides magnetic surgical platform. The company was is headquartered in San Mateo, CA.

Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile.

Levita Magnetics International Corp. provides magnetic surgical platform. The company was is headquartered in San Mateo, CA.

Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.

Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.

Levita Magnetics International Corp. provides magnetic surgical platform. The company was is headquartered in San Mateo, CA.

EchoPixel, Inc. develops medical imaging devices. It offers True 3D viewer 1.0 and True 3D medical education viewer. The firm’s products allows medical professionals to interact with patient-specific organs and tissue in an open 3D space emanating from a display, enabling doctors to immediately identify, evaluate, and dissect clinically significant structures in diagnostic, surgical planning and image guided treatment applications. The company was founded by Sergio Aguirre Valencia in 2005 and is headquartered Mountain View, CA.

Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA.

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Levita Magnetics International Corp. provides magnetic surgical platform. The company was is headquartered in San Mateo, CA.

EchoPixel, Inc. develops medical imaging devices. It offers True 3D viewer 1.0 and True 3D medical education viewer. The firm’s products allows medical professionals to interact with patient-specific organs and tissue in an open 3D space emanating from a display, enabling doctors to immediately identify, evaluate, and dissect clinically significant structures in diagnostic, surgical planning and image guided treatment applications. The company was founded by Sergio Aguirre Valencia in 2005 and is headquartered Mountain View, CA.

Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile.

Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile.